Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Penile Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 42 Melanoma 19 Neoplasms 14 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Skin Neoplasms 11 Lung Neoplasms 10 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma, Basal Cell 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Adenocarcinoma 4 Mycosis Fungoides 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Uveal Melanoma 2

Interventions

Nivolumab 5 Cisplatin 5 pembrolizumab 4 fludarabine 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 aldesleukin 3 Paclitaxel 3 Ipilimumab 3 Ifosfamide 3 fludarabine phosphate 2 entinostat 2 cabozantinib 2 avelumab 2 aflibercept 2 Specimen Handling 2 Radiotherapy 2 CTLA-4 Antigen 2 Biopsy 2 vinflunine 1 toripalimab 1 ripretinib 1 oncogene protein E7, Human papillomavirus type 16 1 niraparib 1 nimotuzumab 1 enfortumab vedotin 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabazitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡